News

This article explores the complex interplay between drug addiction and HIV, highlighting how integrated harm reduction ...
The event — which kicked off on the first day of Pride Month this year — is among the oldest cycling fundraisers for HIV and ...
Learn more about lenacapavir, the most effective HIV treatment and prevention drug, and how its cost could cause a setback.
The FDA approved Gilead's HIV prevention drug lenacapavir, a twice-a-year injectable medication that clinical trials show ...
June 19, 2025 – The FDA has approved the first twice-yearly shot to reduce the risk of HIV infections.
University of Michigan researchers have uncovered new details of the process that HIV uses to hijack cells' transportation ...
The 2025 Warren Alpert Foundation Prize has been awarded to three scientists whose discoveries culminated in the development ...
The US FDA has approved lenacapvir, sold under the brand name Yeztugo, as the first preventive treatment against HIV. It is a ...
The Trump administration's plan to cut funding for HIV vaccine research comes at a time when the field is making substantial ...
Eight million people living with HIV. Just over 6 million on treatment. Behind these big numbers lurk a universe of fascinating epidemiological dynamics. In this special briefing, Spotlight editor ...
aDepartment of Laboratory Medicine, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan bDepartment of Internal Medicine, National Taiwan University ...
Human immunodeficiency virus (HIV) is a germ that causes a lifelong infection that slowly weakens the immune system. Though ...